NO824232L - PROCEDURE FOR THE PREPARATION OF ACEBUTOLOL - Google Patents

PROCEDURE FOR THE PREPARATION OF ACEBUTOLOL

Info

Publication number
NO824232L
NO824232L NO824232A NO824232A NO824232L NO 824232 L NO824232 L NO 824232L NO 824232 A NO824232 A NO 824232A NO 824232 A NO824232 A NO 824232A NO 824232 L NO824232 L NO 824232L
Authority
NO
Norway
Prior art keywords
methyl
dioxalanyl
isopropylamino
propanol
butyramidophenoxy
Prior art date
Application number
NO824232A
Other languages
Norwegian (no)
Inventor
Erkki Juhani Honkanen
Pekka Juhani Kairisalo
Pentti Tapio Nore
Veijo Olavi Ikonen
Aino Kyllikki Pippuri
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of NO824232L publication Critical patent/NO824232L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/06Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton from hydroxy amines by reactions involving the etherification or esterification of hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/30Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
    • C07C233/33Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)

Description

Denne oppfinnelse angår en fremgangsmåte for fremstilling av acebutolol eller l-isopropylamino-3-(2-acetyl-4-butyramido-fenoksy)-2-propanol (I). This invention relates to a process for the production of acebutolol or 1-isopropylamino-3-(2-acetyl-4-butyramido-phenoxy)-2-propanol (I).

Acebutolol er et kjent terapeutisk middel. Acebutolol is a known therapeutic agent.

Britisk patent 1,247.384 beskriver en fremgangsmåte for fremstilling av acebutolol hvor 3-(2-acetyl-4-butyramido-fenoksy)-1,2-propylenoksyd (II) British patent 1,247,384 describes a process for the production of acebutolol where 3-(2-acetyl-4-butyramido-phenoxy)-1,2-propylene oxide (II)

omsettes med isopropylamin. is reacted with isopropylamine.

Japansk publisert patentansøkning 57-2246 (referert i Chem. Abstr. 97: 5962) beskriver en fremgangsmåte for fremstilling av l-isopropylamino-3-(2-allylfenoksy)-, 1-isopropyl-amino-3-fenoksy- eller l-isopropylamino-3-(2-allyloksyfenoksy)-2-propanol, hvor det passende 4-fenoksymetyl-1,3,2-dioksatiolan-2-oksyd (III) Japanese Published Patent Application 57-2246 (referenced in Chem. Abstr. 97: 5962) describes a process for preparing l-isopropylamino-3-(2-allylphenoxy)-, 1-isopropyl-amino-3-phenoxy- or l-isopropylamino -3-(2-allyloxyphenoxy)-2-propanol, where the appropriate 4-phenoxymethyl-1,3,2-dioxathiolane-2-oxide (III)

omsettes med isopropylamin. is reacted with isopropylamine.

Generelle metoder for fremstilling av l-isopropylamino-3-aryloksy-2-propanoler er beskrevet f.eks. i Kemisk Tidskrift, 1976, nr. 10, 48 og i Kemia-Kemi, 1978, nr. 5, 186. General methods for the production of 1-isopropylamino-3-aryloxy-2-propanols are described, e.g. in Kemisk Tidskrift, 1976, no. 10, 48 and in Kemia-Kemi, 1978, no. 5, 186.

Spesielle modifikasjoner for fremstilling av acebutolol er også beskrevet i de finske ålment tilgjengelige patent-ansøkninger 803226 og 803227, Special modifications for the production of acebutolol are also described in the Finnish generally available patent applications 803226 and 803227,

Det er nu funnet at acebutolol kan fremstilles ved at 4-((2-(l-metyl-2,5-dioksalanyl)-4-butyramidofenoksy)metyl)- 1,3,2-dioksatiolan-2-oksyd (IV) It has now been found that acebutolol can be prepared by 4-((2-(1-methyl-2,5-dioxalanyl)-4-butyramidophenoxy)methyl)-1,3,2-dioxathiolane-2-oxide (IV)

omsettes med isopropylamin, og den oppnådde l-isopropylamino-3-(2-(l-metyl-2,5-dioksalany1)-4-butyramidofenoksy)-2-propanol behandles med mineralsyre. Forbindelsen med formel IV er ny. Den kan fremstilles ved at 3-(2-(l-metyl-2,5-dioksalanyl)-4-butyramido-fenoksy)-1,2-propandiol (V) is reacted with isopropylamine, and the obtained 1-isopropylamino-3-(2-(1-methyl-2,5-dioxalanyl)-4-butyramidophenoxy)-2-propanol is treated with mineral acid. The compound with formula IV is new. It can be prepared by 3-(2-(1-methyl-2,5-dioxalanyl)-4-butyramido-phenoxy)-1,2-propanediol (V)

omsettes med tionylklorid. Omsetningen utføres fortrinnsvis i et inert oppløsningsmiddel ved normal eller redusert temperatur i nærvær av et tertiært amin. reacted with thionyl chloride. The reaction is preferably carried out in an inert solvent at normal or reduced temperature in the presence of a tertiary amine.

Forbindelsen med formel V er også ny. Den fremstilles fortrinnsvis ved ketalisering av 2-acetyl-4-butyramidofenol til 2-(l-metyl-2,5-dioksalanyl)-4-butyramidofenol og omsetning av denne med glycidol i nærvær av en basekatalysator. The connection with formula V is also new. It is preferably prepared by ketalizing 2-acetyl-4-butyramidophenol to 2-(1-methyl-2,5-dioxalanyl)-4-butyramidophenol and reacting this with glycidol in the presence of a base catalyst.

Omsetningen av forbindelsen med formel IV med isopropylamin utføres ved oppvarmning av dem i et egnet organisk oppløsnings-middel, fortrinnsvis i acetonitril. The reaction of the compound of formula IV with isopropylamine is carried out by heating them in a suitable organic solvent, preferably in acetonitrile.

Behandling av mellomproduktet l-isopropylamino-3-(2-(l-metyl-2,5-dioksalanyl)-4-butyramidofenoksy)-2-propanol foretas fortrinnsvis i aceton og med saltsyre. Således oppnås lett acebutolol som hydrokloridsaltet søm er den ønskede form for farmasøytiske formål. Treatment of the intermediate product 1-isopropylamino-3-(2-(1-methyl-2,5-dioxalanyl)-4-butyramidophenoxy)-2-propanol is preferably carried out in acetone and with hydrochloric acid. Thus acebutolol is easily obtained as the hydrochloride salt seam is the desired form for pharmaceutical purposes.

De uønskede bireaksjoner er hovedproblemene med den kjente metode ifølge britisk patent 1.247.384. Særlig når forbindelse II fremstilles fra den tilsvarende fenol og epiklorhydrin, reagerer fenolen også med sluttproduktet II. Omsetningen av forbindelse II med isopropylamin fører dessuten lett til den tilsvarende isomere 1-propanol. Det totale utbytte ved fremgangsmåten er forholdsvis lavt, og de nødvendige rensninger gjør fremgangsmåten enda mer uøkonomisk. The unwanted side reactions are the main problems with the known method according to British patent 1,247,384. Especially when compound II is prepared from the corresponding phenol and epichlorohydrin, the phenol also reacts with the final product II. The reaction of compound II with isopropylamine also easily leads to the corresponding isomeric 1-propanol. The total yield of the method is relatively low, and the required purifications make the method even more uneconomical.

Fremgangsmåten ifølge publisert japansk patentansøkning 57-2246 er ikke uten videre anvendelig for fremstilling av acebutolol, fordi 4-((2-acetyl-4-butyramidofenoksy)metyl)-1,3,2-d.ioksatiolan-2-oksyd ikke kan oppnås ved de foreslåtte fremgangsmåter. The process according to published Japanese patent application 57-2246 is not readily applicable to the production of acebutolol, because 4-((2-acetyl-4-butyramidophenoxy)methyl)-1,3,2-d.ioxathiolane-2-oxide cannot be obtained by the proposed methods.

Utbyttet ved fremgangsmåten ifølge oppfinnelsen er høyt,The yield of the method according to the invention is high,

og bare ubetydelige mengder av uønskede biprodukter dannes. Dette gjør at fremgangsmåten også er egnet for industriell fremstilling. and only negligible amounts of unwanted by-products are formed. This means that the method is also suitable for industrial production.

EksempelExample

a) 3-(2-(l-metyl-2,5-dioksalan-2-yl)-4-butyramidofenoksy)-1,2-propandiol (V) a) 3-(2-(1-methyl-2,5-dioxalan-2-yl)-4-butyramidophenoxy)-1,2-propanediol (V)

En oppløsning av 4,5 g (0,06 mol) glycidol i 60 ml 1,1,2-trikloretylen settes langsomt under nitrogen til en kokende oppløsning av 13,3 g (0,05 mol) av 2-(l-metyl-2,5-dioksalanyl)-4-butyramidofenol og en katalytisk mengde natrium-metoksy i 60 ml 1,1,2-trikloretylen. Blandingen tilbakeløps-behandles under nitrogen i 24 timer. Oppløsningsmidlet avdampes i vakuum. 17,0 g (100%) av detønskede produkt oppnås: H<1->NMR (CDC13): 6 = 0,97 (3H t), 1,70 (2H sext), 1,72 (3H s), 2,30 (2H t), 3,50-4,20 (11H m), 6,90 (1H d), 7,50-7,72 (2H m), 9,10 (1H s). A solution of 4.5 g (0.06 mol) of glycidol in 60 ml of 1,1,2-trichloroethylene is slowly added under nitrogen to a boiling solution of 13.3 g (0.05 mol) of 2-(l-methyl -2,5-dioxalanyl)-4-butyramidophenol and a catalytic amount of sodium methoxy in 60 ml of 1,1,2-trichloroethylene. The mixture is refluxed under nitrogen for 24 hours. The solvent is evaporated in vacuo. 17.0 g (100%) of the desired product is obtained: H<1->NMR (CDC13): 6 = 0.97 (3H t), 1.70 (2H sext), 1.72 (3H s), 2 .30 (2H t), 3.50-4.20 (11H m), 6.90 (1H d), 7.50-7.72 (2H m), 9.10 (1H s).

b) 4-((2-(2-metyl-l,3-dioksalan-2-yl)-4-butyramidofenoksy)-metyl)-1,3,2-dioksatiolan-2-oksyd (IV) b) 4-((2-(2-methyl-1,3-dioxalan-2-yl)-4-butyramidophenoxy)-methyl)-1,3,2-dioxathiolane-2-oxide (IV)

En oppløsning av 4,4 ml tionylklorid i 6 ml diklormetan settes til en oppløsning av 17 g (0,06 mol) av forbindelse V og 6,1 g (0,06 mol) av. trietylamin i 60 ml diklormetan ved 0°C. Blandingen omrøres i 15 minutter ved 0-5°C, vaskes med 0,1N saltsyre og vann og tørres med Na2S04, Oppløsningen inndampes til tørrhet i vakuum. 20,7 g (93%) av det ønskede produkt oppnås: H<1->NMR: 0,97 (3H t), 1,70 (3H s), 1,75 (2H sext), 2,30 (2H t), 3,55-4,80 (8H m), 5,20 (1H qu), 6,80 (1H d), 7,40 - 7,65 (1H s). A solution of 4.4 ml of thionyl chloride in 6 ml of dichloromethane is added to a solution of 17 g (0.06 mol) of compound V and 6.1 g (0.06 mol) of triethylamine in 60 ml of dichloromethane at 0°C. The mixture is stirred for 15 minutes at 0-5°C, washed with 0.1N hydrochloric acid and water and dried with Na2S04. The solution is evaporated to dryness in vacuo. 20.7 g (93%) of the desired product is obtained: H<1->NMR: 0.97 (3H t), 1.70 (3H s), 1.75 (2H sext), 2.30 (2H t), 3.55-4.80 (8H m), 5.20 (1H qu), 6.80 (1H d), 7.40 - 7.65 (1H s).

c) l-isopropylamino-3-(2-acetyl-4-butyramidofenoksy)-2-propanol (I) c) 1-isopropylamino-3-(2-acetyl-4-butyramidophenoxy)-2-propanol (I)

19,3 g (0,05 mol) av forbindelse IV og 30 ml isopropylamin i 100 ml acetonitril tilbakeløpsbehandles i 20 timer. Opp-løsningsmidlene fjernes under redusert trykk, og aceton settes til residuet. Blandingen filtreres, og 0,04 mol konsentrert saltsyre tilsettes, 16,4 g (88%) acebutolol-hydroklorid oppnås 19.3 g (0.05 mol) of compound IV and 30 ml of isopropylamine in 100 ml of acetonitrile are refluxed for 20 hours. The solvents are removed under reduced pressure, and acetone is added to the residue. The mixture is filtered, and 0.04 mol of concentrated hydrochloric acid is added, 16.4 g (88%) of acebutolol hydrochloride is obtained

(sirup. 141-143°C) (syrup. 141-143°C)

Claims (7)

1. Fremgangsmåte for fremstilling av l-isopropylamino-3-(2-acetyl-4-butyramidofenoksy)-2-propanol med formelen 1. Process for the production of l-isopropylamino-3-(2-acetyl-4-butyramidophenoxy)-2-propanol with the formula eller salter derav, karakterisert ved at 4-((2-(l-metyl-2,5-dioksalany1)-4-butyramidofenoksy)metyl)-1,3,2-dioksatiolan-2-oksyd med formelen or salts thereof, characterized in that 4-((2-(1-methyl-2,5-dioxalanyl)-4-butyramidophenoxy)methyl)-1,3,2-dioxathiolane-2-oxide with the formula omsettes med isopropylamin, og derefter behandles den oppnådde l-isopropylamino-3-(2-(l-metyl-2,5-dioksalanyl)-4-butyramido-fenoksy)-2-propanol med mineralsyre, og eventuelt omdannes det oppnådde salt til den frie base.is reacted with isopropylamine, and then the obtained l-isopropylamino-3-(2-(1-methyl-2,5-dioxalanyl)-4-butyramido-phenoxy)-2-propanol is treated with mineral acid, and optionally the salt obtained is converted to the free base. 2. Fremgangsmåte ifølge krav 1, karakterisert ved at omsetningen utføres i et organisk oppløsningsmiddel. ri2. Method according to claim 1, characterized in that the reaction is carried out in an organic solvent. ride 3. Fremgangsmåte ifølge _kr$v 2 f/ karakterisert ved at |det som orgjanisk oppløsningsmiddel anvendesj acetonitril.3. Method according to _kr$v 2 f/ characterized in that acetonitrile is used as organic solvent. 4/ Fremgangsmåte ifølge krav , 2', karakterisert ved at 4-( (2-(l-metyl-2,5-dioksalanyl)-4-butyramido-fenoksy)-mety1)-1,3,2-dioksatiolan-2-oksyd tilbakeløpsbehandles med isopropylamin i aceton i ca. 20 timer.4/ Method according to claim , 2', characterized in that 4-( (2-(1-methyl-2,5-dioxalanyl)-4-butyramido-phenoxy)-methyl)-1,3,2-dioxathiolane-2- oxide is refluxed with isopropylamine in acetone for approx. 20 hours. 5. Fremgangsmåte ifølge et av kravene 1 til "4, karakterisert ved at det som mineralsyre anvendes saltsyre.5. Method according to one of claims 1 to "4, characterized in that hydrochloric acid is used as mineral acid. 6 . Fremgangsmåte ifølge et av kravene 1 til 5^, karakterisert ved at behandlingen av l-isopropylamino-3-(2-(l-metyl-2,5-dioksalanyl)-4-butyramido-fenoksy)-2-propanol med mineralsyre foretas i aceton.6. Process according to one of claims 1 to 5, characterized in that the treatment of 1-isopropylamino-3-(2-(1-methyl-2,5-dioxalanyl)-4-butyramido-phenoxy)-2-propanol with mineral acid is carried out in acetone. 7. l-isopropylamino-3-(2-(l-metyl-2,5-dioksalanyl)-4-butyramidofenoksy)-2-propanol.7. 1-isopropylamino-3-(2-(1-methyl-2,5-dioxalanyl)-4-butyramidophenoxy)-2-propanol.
NO824232A 1981-12-17 1982-12-16 PROCEDURE FOR THE PREPARATION OF ACEBUTOLOL NO824232L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI814053 1981-12-17

Publications (1)

Publication Number Publication Date
NO824232L true NO824232L (en) 1983-06-20

Family

ID=8514961

Family Applications (2)

Application Number Title Priority Date Filing Date
NO824233A NO155619C (en) 1981-12-17 1982-12-16 METHOD OF PREPARING METOPROLOL.
NO824232A NO824232L (en) 1981-12-17 1982-12-16 PROCEDURE FOR THE PREPARATION OF ACEBUTOLOL

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO824233A NO155619C (en) 1981-12-17 1982-12-16 METHOD OF PREPARING METOPROLOL.

Country Status (9)

Country Link
JP (2) JPS58159446A (en)
KR (1) KR840002768A (en)
CA (1) CA1198125A (en)
DK (2) DK156567C (en)
HU (1) HU186649B (en)
NO (2) NO155619C (en)
SE (2) SE452612B (en)
SU (1) SU1170968A3 (en)
YU (2) YU275982A (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56152461A (en) * 1980-04-30 1981-11-26 Ota Seiyaku Kk Preparation of indole derivative

Also Published As

Publication number Publication date
SU1170968A3 (en) 1985-07-30
NO824233L (en) 1983-06-20
SE8207198D0 (en) 1982-12-16
NO155619C (en) 1987-04-29
DK542082A (en) 1983-06-18
CA1198125A (en) 1985-12-17
NO155619B (en) 1987-01-19
JPS58159446A (en) 1983-09-21
DK156567B (en) 1989-09-11
SE452612B (en) 1987-12-07
KR840002768A (en) 1984-07-16
DK156567C (en) 1990-03-05
SE8207199D0 (en) 1982-12-16
YU275982A (en) 1985-03-20
DK541982A (en) 1983-06-18
YU275882A (en) 1985-03-20
SE8207198L (en) 1983-06-18
JPS58159449A (en) 1983-09-21
SE8207199L (en) 1983-06-18
HU186649B (en) 1985-08-28

Similar Documents

Publication Publication Date Title
NO152972B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF 2- (1-PHENYL BENZIMIDAZOLYL) -ACETOH HYDROXIC ACID WITH THERAPEUTIC ACTIVITY
NO147751B (en) PROCEDURE FOR THE PREPARATION OF 4-HYDROXYPYRYROLIDIN-2-ON AMIDER.
EP0034461A1 (en) Aromatic aminoethanol compounds and salts thereof, pharmaceutical compositions comprising them and processes for their production
Heine et al. The isomerization of some aziridine derivatives. III. A new synthesis of 2-imidazolines
NO824232L (en) PROCEDURE FOR THE PREPARATION OF ACEBUTOLOL
DE1795651B2 (en) Process for the preparation of 6-substituted 23,5,6-tetrahydroimidazo [2,1-bJ thiazoles
ES2025252B3 (en) PRODUCTION PROCESS OF 1,6 - DI (N3 - CIANO - N1 GUANADINO) HEXANO
JPS6227059B2 (en)
CN113582984A (en) Arotinolol hydrochloride impurity and preparation method and application thereof
CZ2003524A3 (en) Catalytic process for preparing thiazole derivatives
EP0404748B1 (en) Novel stereoisomers
JPS59101491A (en) Synthesis of sorbinill
RU2269526C2 (en) Method for preparing heterocyclic compounds
HU190367B (en) Process for producing 1-carbamoyl-1,3-bracket-3,5-dichloro-phenyl-bracket closed-hidanthoines and the intermediate 1-chloro-carbonyl-3-bracket-3,5-dichloro-phenyl-bracket closed-hidanthoine
JP2007291010A (en) Method for producing optically active 2-methylepihalohydrin or the like
RU2204556C2 (en) Method of synthesis of 1-(para-chlorobenzhydryl)-4-(2-hydroxyethyl)-piperazine
US3873515A (en) Process for producing 2,2{40 -anhydro-(1-{62 -D-ara-binofuranosyl)cytosine
JP3989997B2 (en) Method for producing radiosensitizer
CN106008631A (en) 1,2,4-triazole-3-thioketone derivative containing glucosamine molecules and preparation method and application of derivative
DK143554B (en) METHOD FOR PREPARING 1-TBUTYLAMINO-3- (2,5-DICHLORPHENOXY) -2-PROPANOL OR ANY ACID ADDITION SALT THEREOF
CN112521315B (en) Preparation method of lidocaine degradation impurities
JP2657641B2 (en) Method for producing chloroalkylamine hydrochlorides
SU1217253A3 (en) Method of producing pyrbutyrol dihydrochloride
US5698697A (en) 2-cyanopiperazine and method of producing the same
JPS63211264A (en) Production of indolines